Chun M, Masko G B, Hetelekidis S
Radiation Oncology Department, Tufts New England Medical Center, Boston, MA 02111.
Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):305-9. doi: 10.1016/s0360-3016(98)90009-8.
Between 1970 and 1985, 145 patients were treated for pituitary adenomas and 126 patients were available for analysis. Sixty patients were treated with surgery alone (Group I), 54 were treated with surgery and radiation therapy (Group II), and 12 received irradiation only without tissue diagnosis (Group III). Extent of tumor was evaluated by CT scan, PEG, and surgical reports. There were 22 microadenomas in Group I and only 1 microadenoma in Group II. The mean follow-up was 6.4 years, 85% (51/60) of patients in Group I, 93% of patients in Group II, and only 50% of those treated with irradiation alone achieved tumor control. With subsequent salvage treatment, overall tumor control in Group I was 97%. The mean time to recurrence was 3.7 years (Group I), 4.5 years (Group II), and 4 years (Group III). In summary, combined treatment is effective to decrease the chance of local recurrence of pituitary adenomas. Nevertheless, because of successful salvage treatment after surgical failure, overall outcome is similar. Without persistent symptom after surgery or large residual tumor in or near the critical structures, postoperative irradiation can be deferred until tumor regrowth.
1970年至1985年间,145例垂体腺瘤患者接受了治疗,其中126例可供分析。60例患者仅接受手术治疗(第一组),54例接受手术及放射治疗(第二组),12例仅接受放疗但未进行组织诊断(第三组)。通过CT扫描、PEG及手术报告评估肿瘤范围。第一组有22例微腺瘤,第二组仅有1例微腺瘤。平均随访时间为6.4年,第一组85%(51/60)的患者、第二组93%的患者以及仅接受放疗的患者中50%实现了肿瘤控制。经过后续补救治疗,第一组的总体肿瘤控制率为97%。复发的平均时间为3.7年(第一组)、4.5年(第二组)和4年(第三组)。总之,联合治疗对于降低垂体腺瘤局部复发几率是有效的。然而,由于手术失败后补救治疗成功,总体结果相似。若术后无持续症状或关键结构内或附近无大的残留肿瘤,术后放疗可推迟至肿瘤复发。